Please login to the form below

Not currently logged in
Email:
Password:

Ranbaxy launches generic version of AZ drug

Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US
Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US.

Prilosec, a treatment for conditions caused by excess stomach acid, was originally developed and marketed by AZ and experienced sales in the US of $204.2m, according to IMS data cited by Ranbaxy. Under the terms of the new agreement Ranbaxy Pharmaceuticals - a wholly owned subsidiary of India's largest pharma company, Ranbaxy Laboratories - will begin manufacturing the drug using its generic name, omeprazole.

"We welcome the opportunity to market an authorised generic of omeprazole 40mg capsules that will be commercialised immediately to all classes of trade in the US healthcare system under the Ranbaxy label," said Jim Meehan, vice-president of sales and distribution for RPI.

RPI is based in Florida and markets products to the US healthcare system.

28th July 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics